Global Anti-TIGIT Antibody Market Research Report 2024, Forecast to 2032
Report Overview
A human monoclonal antibody targeting the co-inhibitory molecule and immune checkpoint inhibitor T-cell immunoreceptor with immunoglobulin (Ig) and immunoreceptor tyrosine-based inhibitory motif (ITIM) domains (TIGIT), with potential immune checkpoint inhibitory activity.
The global Anti-TIGIT Antibody market size was estimated at USD 324.80 million in 2023 and is projected to reach USD 1015.26 million by 2032, exhibiting a CAGR of 13.50% during the forecast period.
North America Anti-TIGIT Antibody market size was estimated at USD 105.35 million in 2023, at a CAGR of 11.57% during the forecast period of 2024 through 2032.
This report provides a deep insight into the global Anti-TIGIT Antibody market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Anti-TIGIT Antibody Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Anti-TIGIT Antibody market in any manner.
Global Anti-TIGIT Antibody Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Roche
Merck
AstraZeneca
Arcus
Astellas
BeiGene
BMS
Junshi Biosciences
Innovent Biologics
Mereo BioPharma
Seattle Genetics
Hengrui Medicine
Compugen
Gilead Sciences
Market Segmentation (by Type)
Monotherapy
Combination Therapy
Market Segmentation (by Application)
Cell Carcinoma
Solid Tumor
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Anti-TIGIT Antibody Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region from the consumer side and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Anti-TIGIT Antibody, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region during the forecast period.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment during the forecast period.
Chapter 13 is the main points and conclusions of the report.
A human monoclonal antibody targeting the co-inhibitory molecule and immune checkpoint inhibitor T-cell immunoreceptor with immunoglobulin (Ig) and immunoreceptor tyrosine-based inhibitory motif (ITIM) domains (TIGIT), with potential immune checkpoint inhibitory activity.
The global Anti-TIGIT Antibody market size was estimated at USD 324.80 million in 2023 and is projected to reach USD 1015.26 million by 2032, exhibiting a CAGR of 13.50% during the forecast period.
North America Anti-TIGIT Antibody market size was estimated at USD 105.35 million in 2023, at a CAGR of 11.57% during the forecast period of 2024 through 2032.
This report provides a deep insight into the global Anti-TIGIT Antibody market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Anti-TIGIT Antibody Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Anti-TIGIT Antibody market in any manner.
Global Anti-TIGIT Antibody Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Roche
Merck
AstraZeneca
Arcus
Astellas
BeiGene
BMS
Junshi Biosciences
Innovent Biologics
Mereo BioPharma
Seattle Genetics
Hengrui Medicine
Compugen
Gilead Sciences
Market Segmentation (by Type)
Monotherapy
Combination Therapy
Market Segmentation (by Application)
Cell Carcinoma
Solid Tumor
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Anti-TIGIT Antibody Market
- Overview of the regional outlook of the Anti-TIGIT Antibody Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Anti-TIGIT Antibody Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region from the consumer side and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Anti-TIGIT Antibody, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region during the forecast period.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment during the forecast period.
Chapter 13 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Anti-TIGIT Antibody
1.2 Key Market Segments
1.2.1 Anti-TIGIT Antibody Segment by Type
1.2.2 Anti-TIGIT Antibody Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 ANTI-TIGIT ANTIBODY MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Anti-TIGIT Antibody Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global Anti-TIGIT Antibody Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 ANTI-TIGIT ANTIBODY MARKET COMPETITIVE LANDSCAPE
3.1 Global Anti-TIGIT Antibody Sales by Manufacturers (2019-2024)
3.2 Global Anti-TIGIT Antibody Revenue Market Share by Manufacturers (2019-2024)
3.3 Anti-TIGIT Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Anti-TIGIT Antibody Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Anti-TIGIT Antibody Sales Sites, Area Served, Product Type
3.6 Anti-TIGIT Antibody Market Competitive Situation and Trends
3.6.1 Anti-TIGIT Antibody Market Concentration Rate
3.6.2 Global 5 and 10 Largest Anti-TIGIT Antibody Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 ANTI-TIGIT ANTIBODY INDUSTRY CHAIN ANALYSIS
4.1 Anti-TIGIT Antibody Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF ANTI-TIGIT ANTIBODY MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 ANTI-TIGIT ANTIBODY MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Anti-TIGIT Antibody Sales Market Share by Type (2019-2024)
6.3 Global Anti-TIGIT Antibody Market Size Market Share by Type (2019-2024)
6.4 Global Anti-TIGIT Antibody Price by Type (2019-2024)
7 ANTI-TIGIT ANTIBODY MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Anti-TIGIT Antibody Market Sales by Application (2019-2024)
7.3 Global Anti-TIGIT Antibody Market Size (M USD) by Application (2019-2024)
7.4 Global Anti-TIGIT Antibody Sales Growth Rate by Application (2019-2024)
8 ANTI-TIGIT ANTIBODY MARKET CONSUMPTION BY REGION
8.1 Global Anti-TIGIT Antibody Sales by Region
8.1.1 Global Anti-TIGIT Antibody Sales by Region
8.1.2 Global Anti-TIGIT Antibody Sales Market Share by Region
8.2 North America
8.2.1 North America Anti-TIGIT Antibody Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Anti-TIGIT Antibody Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Anti-TIGIT Antibody Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Anti-TIGIT Antibody Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Anti-TIGIT Antibody Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 ANTI-TIGIT ANTIBODY MARKET PRODUCTION BY REGION
9.1 Global Production of Anti-TIGIT Antibody by Region (2019-2024)
9.2 Global Anti-TIGIT Antibody Revenue Market Share by Region (2019-2024)
9.3 Global Anti-TIGIT Antibody Production, Revenue, Price and Gross Margin (2019-2024)
9.4 North America Anti-TIGIT Antibody Production
9.4.1 North America Anti-TIGIT Antibody Production Growth Rate (2019-2024)
9.4.2 North America Anti-TIGIT Antibody Production, Revenue, Price and Gross Margin (2019-2024)
9.5 Europe Anti-TIGIT Antibody Production
9.5.1 Europe Anti-TIGIT Antibody Production Growth Rate (2019-2024)
9.5.2 Europe Anti-TIGIT Antibody Production, Revenue, Price and Gross Margin (2019-2024)
9.6 Japan Anti-TIGIT Antibody Production (2019-2024)
9.6.1 Japan Anti-TIGIT Antibody Production Growth Rate (2019-2024)
9.6.2 Japan Anti-TIGIT Antibody Production, Revenue, Price and Gross Margin (2019-2024)
9.7 China Anti-TIGIT Antibody Production (2019-2024)
9.7.1 China Anti-TIGIT Antibody Production Growth Rate (2019-2024)
9.7.2 China Anti-TIGIT Antibody Production, Revenue, Price and Gross Margin (2019-2024)
10 KEY COMPANIES PROFILE
10.1 Roche
10.1.1 Roche Anti-TIGIT Antibody Basic Information
10.1.2 Roche Anti-TIGIT Antibody Product Overview
10.1.3 Roche Anti-TIGIT Antibody Product Market Performance
10.1.4 Roche Business Overview
10.1.5 Roche Anti-TIGIT Antibody SWOT Analysis
10.1.6 Roche Recent Developments
10.2 Merck
10.2.1 Merck Anti-TIGIT Antibody Basic Information
10.2.2 Merck Anti-TIGIT Antibody Product Overview
10.2.3 Merck Anti-TIGIT Antibody Product Market Performance
10.2.4 Merck Business Overview
10.2.5 Merck Anti-TIGIT Antibody SWOT Analysis
10.2.6 Merck Recent Developments
10.3 AstraZeneca
10.3.1 AstraZeneca Anti-TIGIT Antibody Basic Information
10.3.2 AstraZeneca Anti-TIGIT Antibody Product Overview
10.3.3 AstraZeneca Anti-TIGIT Antibody Product Market Performance
10.3.4 AstraZeneca Anti-TIGIT Antibody SWOT Analysis
10.3.5 AstraZeneca Business Overview
10.3.6 AstraZeneca Recent Developments
10.4 Arcus
10.4.1 Arcus Anti-TIGIT Antibody Basic Information
10.4.2 Arcus Anti-TIGIT Antibody Product Overview
10.4.3 Arcus Anti-TIGIT Antibody Product Market Performance
10.4.4 Arcus Business Overview
10.4.5 Arcus Recent Developments
10.5 Astellas
10.5.1 Astellas Anti-TIGIT Antibody Basic Information
10.5.2 Astellas Anti-TIGIT Antibody Product Overview
10.5.3 Astellas Anti-TIGIT Antibody Product Market Performance
10.5.4 Astellas Business Overview
10.5.5 Astellas Recent Developments
10.6 BeiGene
10.6.1 BeiGene Anti-TIGIT Antibody Basic Information
10.6.2 BeiGene Anti-TIGIT Antibody Product Overview
10.6.3 BeiGene Anti-TIGIT Antibody Product Market Performance
10.6.4 BeiGene Business Overview
10.6.5 BeiGene Recent Developments
10.7 BMS
10.7.1 BMS Anti-TIGIT Antibody Basic Information
10.7.2 BMS Anti-TIGIT Antibody Product Overview
10.7.3 BMS Anti-TIGIT Antibody Product Market Performance
10.7.4 BMS Business Overview
10.7.5 BMS Recent Developments
10.8 Junshi Biosciences
10.8.1 Junshi Biosciences Anti-TIGIT Antibody Basic Information
10.8.2 Junshi Biosciences Anti-TIGIT Antibody Product Overview
10.8.3 Junshi Biosciences Anti-TIGIT Antibody Product Market Performance
10.8.4 Junshi Biosciences Business Overview
10.8.5 Junshi Biosciences Recent Developments
10.9 Innovent Biologics
10.9.1 Innovent Biologics Anti-TIGIT Antibody Basic Information
10.9.2 Innovent Biologics Anti-TIGIT Antibody Product Overview
10.9.3 Innovent Biologics Anti-TIGIT Antibody Product Market Performance
10.9.4 Innovent Biologics Business Overview
10.9.5 Innovent Biologics Recent Developments
10.10 Mereo BioPharma
10.10.1 Mereo BioPharma Anti-TIGIT Antibody Basic Information
10.10.2 Mereo BioPharma Anti-TIGIT Antibody Product Overview
10.10.3 Mereo BioPharma Anti-TIGIT Antibody Product Market Performance
10.10.4 Mereo BioPharma Business Overview
10.10.5 Mereo BioPharma Recent Developments
10.11 Seattle Genetics
10.11.1 Seattle Genetics Anti-TIGIT Antibody Basic Information
10.11.2 Seattle Genetics Anti-TIGIT Antibody Product Overview
10.11.3 Seattle Genetics Anti-TIGIT Antibody Product Market Performance
10.11.4 Seattle Genetics Business Overview
10.11.5 Seattle Genetics Recent Developments
10.12 Hengrui Medicine
10.12.1 Hengrui Medicine Anti-TIGIT Antibody Basic Information
10.12.2 Hengrui Medicine Anti-TIGIT Antibody Product Overview
10.12.3 Hengrui Medicine Anti-TIGIT Antibody Product Market Performance
10.12.4 Hengrui Medicine Business Overview
10.12.5 Hengrui Medicine Recent Developments
10.13 Compugen
10.13.1 Compugen Anti-TIGIT Antibody Basic Information
10.13.2 Compugen Anti-TIGIT Antibody Product Overview
10.13.3 Compugen Anti-TIGIT Antibody Product Market Performance
10.13.4 Compugen Business Overview
10.13.5 Compugen Recent Developments
10.14 Gilead Sciences
10.14.1 Gilead Sciences Anti-TIGIT Antibody Basic Information
10.14.2 Gilead Sciences Anti-TIGIT Antibody Product Overview
10.14.3 Gilead Sciences Anti-TIGIT Antibody Product Market Performance
10.14.4 Gilead Sciences Business Overview
10.14.5 Gilead Sciences Recent Developments
11 ANTI-TIGIT ANTIBODY MARKET FORECAST BY REGION
11.1 Global Anti-TIGIT Antibody Market Size Forecast
11.2 Global Anti-TIGIT Antibody Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Anti-TIGIT Antibody Market Size Forecast by Country
11.2.3 Asia Pacific Anti-TIGIT Antibody Market Size Forecast by Region
11.2.4 South America Anti-TIGIT Antibody Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of Anti-TIGIT Antibody by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2032)
12.1 Global Anti-TIGIT Antibody Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of Anti-TIGIT Antibody by Type (2025-2032)
12.1.2 Global Anti-TIGIT Antibody Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of Anti-TIGIT Antibody by Type (2025-2032)
12.2 Global Anti-TIGIT Antibody Market Forecast by Application (2025-2032)
12.2.1 Global Anti-TIGIT Antibody Sales (K MT) Forecast by Application
12.2.2 Global Anti-TIGIT Antibody Market Size (M USD) Forecast by Application (2025-2032)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Anti-TIGIT Antibody
1.2 Key Market Segments
1.2.1 Anti-TIGIT Antibody Segment by Type
1.2.2 Anti-TIGIT Antibody Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 ANTI-TIGIT ANTIBODY MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Anti-TIGIT Antibody Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global Anti-TIGIT Antibody Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 ANTI-TIGIT ANTIBODY MARKET COMPETITIVE LANDSCAPE
3.1 Global Anti-TIGIT Antibody Sales by Manufacturers (2019-2024)
3.2 Global Anti-TIGIT Antibody Revenue Market Share by Manufacturers (2019-2024)
3.3 Anti-TIGIT Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Anti-TIGIT Antibody Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Anti-TIGIT Antibody Sales Sites, Area Served, Product Type
3.6 Anti-TIGIT Antibody Market Competitive Situation and Trends
3.6.1 Anti-TIGIT Antibody Market Concentration Rate
3.6.2 Global 5 and 10 Largest Anti-TIGIT Antibody Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 ANTI-TIGIT ANTIBODY INDUSTRY CHAIN ANALYSIS
4.1 Anti-TIGIT Antibody Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF ANTI-TIGIT ANTIBODY MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 ANTI-TIGIT ANTIBODY MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Anti-TIGIT Antibody Sales Market Share by Type (2019-2024)
6.3 Global Anti-TIGIT Antibody Market Size Market Share by Type (2019-2024)
6.4 Global Anti-TIGIT Antibody Price by Type (2019-2024)
7 ANTI-TIGIT ANTIBODY MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Anti-TIGIT Antibody Market Sales by Application (2019-2024)
7.3 Global Anti-TIGIT Antibody Market Size (M USD) by Application (2019-2024)
7.4 Global Anti-TIGIT Antibody Sales Growth Rate by Application (2019-2024)
8 ANTI-TIGIT ANTIBODY MARKET CONSUMPTION BY REGION
8.1 Global Anti-TIGIT Antibody Sales by Region
8.1.1 Global Anti-TIGIT Antibody Sales by Region
8.1.2 Global Anti-TIGIT Antibody Sales Market Share by Region
8.2 North America
8.2.1 North America Anti-TIGIT Antibody Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Anti-TIGIT Antibody Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Anti-TIGIT Antibody Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Anti-TIGIT Antibody Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Anti-TIGIT Antibody Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 ANTI-TIGIT ANTIBODY MARKET PRODUCTION BY REGION
9.1 Global Production of Anti-TIGIT Antibody by Region (2019-2024)
9.2 Global Anti-TIGIT Antibody Revenue Market Share by Region (2019-2024)
9.3 Global Anti-TIGIT Antibody Production, Revenue, Price and Gross Margin (2019-2024)
9.4 North America Anti-TIGIT Antibody Production
9.4.1 North America Anti-TIGIT Antibody Production Growth Rate (2019-2024)
9.4.2 North America Anti-TIGIT Antibody Production, Revenue, Price and Gross Margin (2019-2024)
9.5 Europe Anti-TIGIT Antibody Production
9.5.1 Europe Anti-TIGIT Antibody Production Growth Rate (2019-2024)
9.5.2 Europe Anti-TIGIT Antibody Production, Revenue, Price and Gross Margin (2019-2024)
9.6 Japan Anti-TIGIT Antibody Production (2019-2024)
9.6.1 Japan Anti-TIGIT Antibody Production Growth Rate (2019-2024)
9.6.2 Japan Anti-TIGIT Antibody Production, Revenue, Price and Gross Margin (2019-2024)
9.7 China Anti-TIGIT Antibody Production (2019-2024)
9.7.1 China Anti-TIGIT Antibody Production Growth Rate (2019-2024)
9.7.2 China Anti-TIGIT Antibody Production, Revenue, Price and Gross Margin (2019-2024)
10 KEY COMPANIES PROFILE
10.1 Roche
10.1.1 Roche Anti-TIGIT Antibody Basic Information
10.1.2 Roche Anti-TIGIT Antibody Product Overview
10.1.3 Roche Anti-TIGIT Antibody Product Market Performance
10.1.4 Roche Business Overview
10.1.5 Roche Anti-TIGIT Antibody SWOT Analysis
10.1.6 Roche Recent Developments
10.2 Merck
10.2.1 Merck Anti-TIGIT Antibody Basic Information
10.2.2 Merck Anti-TIGIT Antibody Product Overview
10.2.3 Merck Anti-TIGIT Antibody Product Market Performance
10.2.4 Merck Business Overview
10.2.5 Merck Anti-TIGIT Antibody SWOT Analysis
10.2.6 Merck Recent Developments
10.3 AstraZeneca
10.3.1 AstraZeneca Anti-TIGIT Antibody Basic Information
10.3.2 AstraZeneca Anti-TIGIT Antibody Product Overview
10.3.3 AstraZeneca Anti-TIGIT Antibody Product Market Performance
10.3.4 AstraZeneca Anti-TIGIT Antibody SWOT Analysis
10.3.5 AstraZeneca Business Overview
10.3.6 AstraZeneca Recent Developments
10.4 Arcus
10.4.1 Arcus Anti-TIGIT Antibody Basic Information
10.4.2 Arcus Anti-TIGIT Antibody Product Overview
10.4.3 Arcus Anti-TIGIT Antibody Product Market Performance
10.4.4 Arcus Business Overview
10.4.5 Arcus Recent Developments
10.5 Astellas
10.5.1 Astellas Anti-TIGIT Antibody Basic Information
10.5.2 Astellas Anti-TIGIT Antibody Product Overview
10.5.3 Astellas Anti-TIGIT Antibody Product Market Performance
10.5.4 Astellas Business Overview
10.5.5 Astellas Recent Developments
10.6 BeiGene
10.6.1 BeiGene Anti-TIGIT Antibody Basic Information
10.6.2 BeiGene Anti-TIGIT Antibody Product Overview
10.6.3 BeiGene Anti-TIGIT Antibody Product Market Performance
10.6.4 BeiGene Business Overview
10.6.5 BeiGene Recent Developments
10.7 BMS
10.7.1 BMS Anti-TIGIT Antibody Basic Information
10.7.2 BMS Anti-TIGIT Antibody Product Overview
10.7.3 BMS Anti-TIGIT Antibody Product Market Performance
10.7.4 BMS Business Overview
10.7.5 BMS Recent Developments
10.8 Junshi Biosciences
10.8.1 Junshi Biosciences Anti-TIGIT Antibody Basic Information
10.8.2 Junshi Biosciences Anti-TIGIT Antibody Product Overview
10.8.3 Junshi Biosciences Anti-TIGIT Antibody Product Market Performance
10.8.4 Junshi Biosciences Business Overview
10.8.5 Junshi Biosciences Recent Developments
10.9 Innovent Biologics
10.9.1 Innovent Biologics Anti-TIGIT Antibody Basic Information
10.9.2 Innovent Biologics Anti-TIGIT Antibody Product Overview
10.9.3 Innovent Biologics Anti-TIGIT Antibody Product Market Performance
10.9.4 Innovent Biologics Business Overview
10.9.5 Innovent Biologics Recent Developments
10.10 Mereo BioPharma
10.10.1 Mereo BioPharma Anti-TIGIT Antibody Basic Information
10.10.2 Mereo BioPharma Anti-TIGIT Antibody Product Overview
10.10.3 Mereo BioPharma Anti-TIGIT Antibody Product Market Performance
10.10.4 Mereo BioPharma Business Overview
10.10.5 Mereo BioPharma Recent Developments
10.11 Seattle Genetics
10.11.1 Seattle Genetics Anti-TIGIT Antibody Basic Information
10.11.2 Seattle Genetics Anti-TIGIT Antibody Product Overview
10.11.3 Seattle Genetics Anti-TIGIT Antibody Product Market Performance
10.11.4 Seattle Genetics Business Overview
10.11.5 Seattle Genetics Recent Developments
10.12 Hengrui Medicine
10.12.1 Hengrui Medicine Anti-TIGIT Antibody Basic Information
10.12.2 Hengrui Medicine Anti-TIGIT Antibody Product Overview
10.12.3 Hengrui Medicine Anti-TIGIT Antibody Product Market Performance
10.12.4 Hengrui Medicine Business Overview
10.12.5 Hengrui Medicine Recent Developments
10.13 Compugen
10.13.1 Compugen Anti-TIGIT Antibody Basic Information
10.13.2 Compugen Anti-TIGIT Antibody Product Overview
10.13.3 Compugen Anti-TIGIT Antibody Product Market Performance
10.13.4 Compugen Business Overview
10.13.5 Compugen Recent Developments
10.14 Gilead Sciences
10.14.1 Gilead Sciences Anti-TIGIT Antibody Basic Information
10.14.2 Gilead Sciences Anti-TIGIT Antibody Product Overview
10.14.3 Gilead Sciences Anti-TIGIT Antibody Product Market Performance
10.14.4 Gilead Sciences Business Overview
10.14.5 Gilead Sciences Recent Developments
11 ANTI-TIGIT ANTIBODY MARKET FORECAST BY REGION
11.1 Global Anti-TIGIT Antibody Market Size Forecast
11.2 Global Anti-TIGIT Antibody Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Anti-TIGIT Antibody Market Size Forecast by Country
11.2.3 Asia Pacific Anti-TIGIT Antibody Market Size Forecast by Region
11.2.4 South America Anti-TIGIT Antibody Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of Anti-TIGIT Antibody by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2032)
12.1 Global Anti-TIGIT Antibody Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of Anti-TIGIT Antibody by Type (2025-2032)
12.1.2 Global Anti-TIGIT Antibody Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of Anti-TIGIT Antibody by Type (2025-2032)
12.2 Global Anti-TIGIT Antibody Market Forecast by Application (2025-2032)
12.2.1 Global Anti-TIGIT Antibody Sales (K MT) Forecast by Application
12.2.2 Global Anti-TIGIT Antibody Market Size (M USD) Forecast by Application (2025-2032)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Anti-TIGIT Antibody Market Size Comparison by Region (M USD)
Table 5. Global Anti-TIGIT Antibody Sales (K MT) by Manufacturers (2019-2024)
Table 6. Global Anti-TIGIT Antibody Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Anti-TIGIT Antibody Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Anti-TIGIT Antibody Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-TIGIT Antibody as of 2022)
Table 10. Global Market Anti-TIGIT Antibody Average Price (USD/MT) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Anti-TIGIT Antibody Sales Sites and Area Served
Table 12. Manufacturers Anti-TIGIT Antibody Product Type
Table 13. Global Anti-TIGIT Antibody Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Anti-TIGIT Antibody
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Anti-TIGIT Antibody Market Challenges
Table 22. Global Anti-TIGIT Antibody Sales by Type (K MT)
Table 23. Global Anti-TIGIT Antibody Market Size by Type (M USD)
Table 24. Global Anti-TIGIT Antibody Sales (K MT) by Type (2019-2024)
Table 25. Global Anti-TIGIT Antibody Sales Market Share by Type (2019-2024)
Table 26. Global Anti-TIGIT Antibody Market Size (M USD) by Type (2019-2024)
Table 27. Global Anti-TIGIT Antibody Market Size Share by Type (2019-2024)
Table 28. Global Anti-TIGIT Antibody Price (USD/MT) by Type (2019-2024)
Table 29. Global Anti-TIGIT Antibody Sales (K MT) by Application
Table 30. Global Anti-TIGIT Antibody Market Size by Application
Table 31. Global Anti-TIGIT Antibody Sales by Application (2019-2024) & (K MT)
Table 32. Global Anti-TIGIT Antibody Sales Market Share by Application (2019-2024)
Table 33. Global Anti-TIGIT Antibody Sales by Application (2019-2024) & (M USD)
Table 34. Global Anti-TIGIT Antibody Market Share by Application (2019-2024)
Table 35. Global Anti-TIGIT Antibody Sales Growth Rate by Application (2019-2024)
Table 36. Global Anti-TIGIT Antibody Sales by Region (2019-2024) & (K MT)
Table 37. Global Anti-TIGIT Antibody Sales Market Share by Region (2019-2024)
Table 38. North America Anti-TIGIT Antibody Sales by Country (2019-2024) & (K MT)
Table 39. Europe Anti-TIGIT Antibody Sales by Country (2019-2024) & (K MT)
Table 40. Asia Pacific Anti-TIGIT Antibody Sales by Region (2019-2024) & (K MT)
Table 41. South America Anti-TIGIT Antibody Sales by Country (2019-2024) & (K MT)
Table 42. Middle East and Africa Anti-TIGIT Antibody Sales by Region (2019-2024) & (K MT)
Table 43. Global Anti-TIGIT Antibody Production (K MT) by Region (2019-2024)
Table 44. Global Anti-TIGIT Antibody Revenue (US$ Million) by Region (2019-2024)
Table 45. Global Anti-TIGIT Antibody Revenue Market Share by Region (2019-2024)
Table 46. Global Anti-TIGIT Antibody Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 47. North America Anti-TIGIT Antibody Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 48. Europe Anti-TIGIT Antibody Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 49. Japan Anti-TIGIT Antibody Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 50. China Anti-TIGIT Antibody Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 51. Roche Anti-TIGIT Antibody Basic Information
Table 52. Roche Anti-TIGIT Antibody Product Overview
Table 53. Roche Anti-TIGIT Antibody Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 54. Roche Business Overview
Table 55. Roche Anti-TIGIT Antibody SWOT Analysis
Table 56. Roche Recent Developments
Table 57. Merck Anti-TIGIT Antibody Basic Information
Table 58. Merck Anti-TIGIT Antibody Product Overview
Table 59. Merck Anti-TIGIT Antibody Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 60. Merck Business Overview
Table 61. Merck Anti-TIGIT Antibody SWOT Analysis
Table 62. Merck Recent Developments
Table 63. AstraZeneca Anti-TIGIT Antibody Basic Information
Table 64. AstraZeneca Anti-TIGIT Antibody Product Overview
Table 65. AstraZeneca Anti-TIGIT Antibody Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 66. AstraZeneca Anti-TIGIT Antibody SWOT Analysis
Table 67. AstraZeneca Business Overview
Table 68. AstraZeneca Recent Developments
Table 69. Arcus Anti-TIGIT Antibody Basic Information
Table 70. Arcus Anti-TIGIT Antibody Product Overview
Table 71. Arcus Anti-TIGIT Antibody Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 72. Arcus Business Overview
Table 73. Arcus Recent Developments
Table 74. Astellas Anti-TIGIT Antibody Basic Information
Table 75. Astellas Anti-TIGIT Antibody Product Overview
Table 76. Astellas Anti-TIGIT Antibody Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 77. Astellas Business Overview
Table 78. Astellas Recent Developments
Table 79. BeiGene Anti-TIGIT Antibody Basic Information
Table 80. BeiGene Anti-TIGIT Antibody Product Overview
Table 81. BeiGene Anti-TIGIT Antibody Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 82. BeiGene Business Overview
Table 83. BeiGene Recent Developments
Table 84. BMS Anti-TIGIT Antibody Basic Information
Table 85. BMS Anti-TIGIT Antibody Product Overview
Table 86. BMS Anti-TIGIT Antibody Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 87. BMS Business Overview
Table 88. BMS Recent Developments
Table 89. Junshi Biosciences Anti-TIGIT Antibody Basic Information
Table 90. Junshi Biosciences Anti-TIGIT Antibody Product Overview
Table 91. Junshi Biosciences Anti-TIGIT Antibody Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 92. Junshi Biosciences Business Overview
Table 93. Junshi Biosciences Recent Developments
Table 94. Innovent Biologics Anti-TIGIT Antibody Basic Information
Table 95. Innovent Biologics Anti-TIGIT Antibody Product Overview
Table 96. Innovent Biologics Anti-TIGIT Antibody Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 97. Innovent Biologics Business Overview
Table 98. Innovent Biologics Recent Developments
Table 99. Mereo BioPharma Anti-TIGIT Antibody Basic Information
Table 100. Mereo BioPharma Anti-TIGIT Antibody Product Overview
Table 101. Mereo BioPharma Anti-TIGIT Antibody Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 102. Mereo BioPharma Business Overview
Table 103. Mereo BioPharma Recent Developments
Table 104. Seattle Genetics Anti-TIGIT Antibody Basic Information
Table 105. Seattle Genetics Anti-TIGIT Antibody Product Overview
Table 106. Seattle Genetics Anti-TIGIT Antibody Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 107. Seattle Genetics Business Overview
Table 108. Seattle Genetics Recent Developments
Table 109. Hengrui Medicine Anti-TIGIT Antibody Basic Information
Table 110. Hengrui Medicine Anti-TIGIT Antibody Product Overview
Table 111. Hengrui Medicine Anti-TIGIT Antibody Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 112. Hengrui Medicine Business Overview
Table 113. Hengrui Medicine Recent Developments
Table 114. Compugen Anti-TIGIT Antibody Basic Information
Table 115. Compugen Anti-TIGIT Antibody Product Overview
Table 116. Compugen Anti-TIGIT Antibody Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 117. Compugen Business Overview
Table 118. Compugen Recent Developments
Table 119. Gilead Sciences Anti-TIGIT Antibody Basic Information
Table 120. Gilead Sciences Anti-TIGIT Antibody Product Overview
Table 121. Gilead Sciences Anti-TIGIT Antibody Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 122. Gilead Sciences Business Overview
Table 123. Gilead Sciences Recent Developments
Table 124. Global Anti-TIGIT Antibody Sales Forecast by Region (2025-2032) & (K MT)
Table 125. Global Anti-TIGIT Antibody Market Size Forecast by Region (2025-2032) & (M USD)
Table 126. North America Anti-TIGIT Antibody Sales Forecast by Country (2025-2032) & (K MT)
Table 127. North America Anti-TIGIT Antibody Market Size Forecast by Country (2025-2032) & (M USD)
Table 128. Europe Anti-TIGIT Antibody Sales Forecast by Country (2025-2032) & (K MT)
Table 129. Europe Anti-TIGIT Antibody Market Size Forecast by Country (2025-2032) & (M USD)
Table 130. Asia Pacific Anti-TIGIT Antibody Sales Forecast by Region (2025-2032) & (K MT)
Table 131. Asia Pacific Anti-TIGIT Antibody Market Size Forecast by Region (2025-2032) & (M USD)
Table 132. South America Anti-TIGIT Antibody Sales Forecast by Country (2025-2032) & (K MT)
Table 133. South America Anti-TIGIT Antibody Market Size Forecast by Country (2025-2032) & (M USD)
Table 134. Middle East and Africa Anti-TIGIT Antibody Consumption Forecast by Country (2025-2032) & (Units)
Table 135. Middle East and Africa Anti-TIGIT Antibody Market Size Forecast by Country (2025-2032) & (M USD)
Table 136. Global Anti-TIGIT Antibody Sales Forecast by Type (2025-2032) & (K MT)
Table 137. Global Anti-TIGIT Antibody Market Size Forecast by Type (2025-2032) & (M USD)
Table 138. Global Anti-TIGIT Antibody Price Forecast by Type (2025-2032) & (USD/MT)
Table 139. Global Anti-TIGIT Antibody Sales (K MT) Forecast by Application (2025-2032)
Table 140. Global Anti-TIGIT Antibody Market Size Forecast by Application (2025-2032) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Anti-TIGIT Antibody Market Size Comparison by Region (M USD)
Table 5. Global Anti-TIGIT Antibody Sales (K MT) by Manufacturers (2019-2024)
Table 6. Global Anti-TIGIT Antibody Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Anti-TIGIT Antibody Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Anti-TIGIT Antibody Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-TIGIT Antibody as of 2022)
Table 10. Global Market Anti-TIGIT Antibody Average Price (USD/MT) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Anti-TIGIT Antibody Sales Sites and Area Served
Table 12. Manufacturers Anti-TIGIT Antibody Product Type
Table 13. Global Anti-TIGIT Antibody Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Anti-TIGIT Antibody
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Anti-TIGIT Antibody Market Challenges
Table 22. Global Anti-TIGIT Antibody Sales by Type (K MT)
Table 23. Global Anti-TIGIT Antibody Market Size by Type (M USD)
Table 24. Global Anti-TIGIT Antibody Sales (K MT) by Type (2019-2024)
Table 25. Global Anti-TIGIT Antibody Sales Market Share by Type (2019-2024)
Table 26. Global Anti-TIGIT Antibody Market Size (M USD) by Type (2019-2024)
Table 27. Global Anti-TIGIT Antibody Market Size Share by Type (2019-2024)
Table 28. Global Anti-TIGIT Antibody Price (USD/MT) by Type (2019-2024)
Table 29. Global Anti-TIGIT Antibody Sales (K MT) by Application
Table 30. Global Anti-TIGIT Antibody Market Size by Application
Table 31. Global Anti-TIGIT Antibody Sales by Application (2019-2024) & (K MT)
Table 32. Global Anti-TIGIT Antibody Sales Market Share by Application (2019-2024)
Table 33. Global Anti-TIGIT Antibody Sales by Application (2019-2024) & (M USD)
Table 34. Global Anti-TIGIT Antibody Market Share by Application (2019-2024)
Table 35. Global Anti-TIGIT Antibody Sales Growth Rate by Application (2019-2024)
Table 36. Global Anti-TIGIT Antibody Sales by Region (2019-2024) & (K MT)
Table 37. Global Anti-TIGIT Antibody Sales Market Share by Region (2019-2024)
Table 38. North America Anti-TIGIT Antibody Sales by Country (2019-2024) & (K MT)
Table 39. Europe Anti-TIGIT Antibody Sales by Country (2019-2024) & (K MT)
Table 40. Asia Pacific Anti-TIGIT Antibody Sales by Region (2019-2024) & (K MT)
Table 41. South America Anti-TIGIT Antibody Sales by Country (2019-2024) & (K MT)
Table 42. Middle East and Africa Anti-TIGIT Antibody Sales by Region (2019-2024) & (K MT)
Table 43. Global Anti-TIGIT Antibody Production (K MT) by Region (2019-2024)
Table 44. Global Anti-TIGIT Antibody Revenue (US$ Million) by Region (2019-2024)
Table 45. Global Anti-TIGIT Antibody Revenue Market Share by Region (2019-2024)
Table 46. Global Anti-TIGIT Antibody Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 47. North America Anti-TIGIT Antibody Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 48. Europe Anti-TIGIT Antibody Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 49. Japan Anti-TIGIT Antibody Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 50. China Anti-TIGIT Antibody Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 51. Roche Anti-TIGIT Antibody Basic Information
Table 52. Roche Anti-TIGIT Antibody Product Overview
Table 53. Roche Anti-TIGIT Antibody Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 54. Roche Business Overview
Table 55. Roche Anti-TIGIT Antibody SWOT Analysis
Table 56. Roche Recent Developments
Table 57. Merck Anti-TIGIT Antibody Basic Information
Table 58. Merck Anti-TIGIT Antibody Product Overview
Table 59. Merck Anti-TIGIT Antibody Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 60. Merck Business Overview
Table 61. Merck Anti-TIGIT Antibody SWOT Analysis
Table 62. Merck Recent Developments
Table 63. AstraZeneca Anti-TIGIT Antibody Basic Information
Table 64. AstraZeneca Anti-TIGIT Antibody Product Overview
Table 65. AstraZeneca Anti-TIGIT Antibody Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 66. AstraZeneca Anti-TIGIT Antibody SWOT Analysis
Table 67. AstraZeneca Business Overview
Table 68. AstraZeneca Recent Developments
Table 69. Arcus Anti-TIGIT Antibody Basic Information
Table 70. Arcus Anti-TIGIT Antibody Product Overview
Table 71. Arcus Anti-TIGIT Antibody Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 72. Arcus Business Overview
Table 73. Arcus Recent Developments
Table 74. Astellas Anti-TIGIT Antibody Basic Information
Table 75. Astellas Anti-TIGIT Antibody Product Overview
Table 76. Astellas Anti-TIGIT Antibody Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 77. Astellas Business Overview
Table 78. Astellas Recent Developments
Table 79. BeiGene Anti-TIGIT Antibody Basic Information
Table 80. BeiGene Anti-TIGIT Antibody Product Overview
Table 81. BeiGene Anti-TIGIT Antibody Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 82. BeiGene Business Overview
Table 83. BeiGene Recent Developments
Table 84. BMS Anti-TIGIT Antibody Basic Information
Table 85. BMS Anti-TIGIT Antibody Product Overview
Table 86. BMS Anti-TIGIT Antibody Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 87. BMS Business Overview
Table 88. BMS Recent Developments
Table 89. Junshi Biosciences Anti-TIGIT Antibody Basic Information
Table 90. Junshi Biosciences Anti-TIGIT Antibody Product Overview
Table 91. Junshi Biosciences Anti-TIGIT Antibody Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 92. Junshi Biosciences Business Overview
Table 93. Junshi Biosciences Recent Developments
Table 94. Innovent Biologics Anti-TIGIT Antibody Basic Information
Table 95. Innovent Biologics Anti-TIGIT Antibody Product Overview
Table 96. Innovent Biologics Anti-TIGIT Antibody Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 97. Innovent Biologics Business Overview
Table 98. Innovent Biologics Recent Developments
Table 99. Mereo BioPharma Anti-TIGIT Antibody Basic Information
Table 100. Mereo BioPharma Anti-TIGIT Antibody Product Overview
Table 101. Mereo BioPharma Anti-TIGIT Antibody Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 102. Mereo BioPharma Business Overview
Table 103. Mereo BioPharma Recent Developments
Table 104. Seattle Genetics Anti-TIGIT Antibody Basic Information
Table 105. Seattle Genetics Anti-TIGIT Antibody Product Overview
Table 106. Seattle Genetics Anti-TIGIT Antibody Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 107. Seattle Genetics Business Overview
Table 108. Seattle Genetics Recent Developments
Table 109. Hengrui Medicine Anti-TIGIT Antibody Basic Information
Table 110. Hengrui Medicine Anti-TIGIT Antibody Product Overview
Table 111. Hengrui Medicine Anti-TIGIT Antibody Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 112. Hengrui Medicine Business Overview
Table 113. Hengrui Medicine Recent Developments
Table 114. Compugen Anti-TIGIT Antibody Basic Information
Table 115. Compugen Anti-TIGIT Antibody Product Overview
Table 116. Compugen Anti-TIGIT Antibody Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 117. Compugen Business Overview
Table 118. Compugen Recent Developments
Table 119. Gilead Sciences Anti-TIGIT Antibody Basic Information
Table 120. Gilead Sciences Anti-TIGIT Antibody Product Overview
Table 121. Gilead Sciences Anti-TIGIT Antibody Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 122. Gilead Sciences Business Overview
Table 123. Gilead Sciences Recent Developments
Table 124. Global Anti-TIGIT Antibody Sales Forecast by Region (2025-2032) & (K MT)
Table 125. Global Anti-TIGIT Antibody Market Size Forecast by Region (2025-2032) & (M USD)
Table 126. North America Anti-TIGIT Antibody Sales Forecast by Country (2025-2032) & (K MT)
Table 127. North America Anti-TIGIT Antibody Market Size Forecast by Country (2025-2032) & (M USD)
Table 128. Europe Anti-TIGIT Antibody Sales Forecast by Country (2025-2032) & (K MT)
Table 129. Europe Anti-TIGIT Antibody Market Size Forecast by Country (2025-2032) & (M USD)
Table 130. Asia Pacific Anti-TIGIT Antibody Sales Forecast by Region (2025-2032) & (K MT)
Table 131. Asia Pacific Anti-TIGIT Antibody Market Size Forecast by Region (2025-2032) & (M USD)
Table 132. South America Anti-TIGIT Antibody Sales Forecast by Country (2025-2032) & (K MT)
Table 133. South America Anti-TIGIT Antibody Market Size Forecast by Country (2025-2032) & (M USD)
Table 134. Middle East and Africa Anti-TIGIT Antibody Consumption Forecast by Country (2025-2032) & (Units)
Table 135. Middle East and Africa Anti-TIGIT Antibody Market Size Forecast by Country (2025-2032) & (M USD)
Table 136. Global Anti-TIGIT Antibody Sales Forecast by Type (2025-2032) & (K MT)
Table 137. Global Anti-TIGIT Antibody Market Size Forecast by Type (2025-2032) & (M USD)
Table 138. Global Anti-TIGIT Antibody Price Forecast by Type (2025-2032) & (USD/MT)
Table 139. Global Anti-TIGIT Antibody Sales (K MT) Forecast by Application (2025-2032)
Table 140. Global Anti-TIGIT Antibody Market Size Forecast by Application (2025-2032) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Anti-TIGIT Antibody
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Anti-TIGIT Antibody Market Size (M USD), 2019-2032
Figure 5. Global Anti-TIGIT Antibody Market Size (M USD) (2019-2032)
Figure 6. Global Anti-TIGIT Antibody Sales (K MT) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Anti-TIGIT Antibody Market Size by Country (M USD)
Figure 11. Anti-TIGIT Antibody Sales Share by Manufacturers in 2023
Figure 12. Global Anti-TIGIT Antibody Revenue Share by Manufacturers in 2023
Figure 13. Anti-TIGIT Antibody Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Anti-TIGIT Antibody Average Price (USD/MT) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Anti-TIGIT Antibody Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Anti-TIGIT Antibody Market Share by Type
Figure 18. Sales Market Share of Anti-TIGIT Antibody by Type (2019-2024)
Figure 19. Sales Market Share of Anti-TIGIT Antibody by Type in 2023
Figure 20. Market Size Share of Anti-TIGIT Antibody by Type (2019-2024)
Figure 21. Market Size Market Share of Anti-TIGIT Antibody by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Anti-TIGIT Antibody Market Share by Application
Figure 24. Global Anti-TIGIT Antibody Sales Market Share by Application (2019-2024)
Figure 25. Global Anti-TIGIT Antibody Sales Market Share by Application in 2023
Figure 26. Global Anti-TIGIT Antibody Market Share by Application (2019-2024)
Figure 27. Global Anti-TIGIT Antibody Market Share by Application in 2023
Figure 28. Global Anti-TIGIT Antibody Sales Growth Rate by Application (2019-2024)
Figure 29. Global Anti-TIGIT Antibody Sales Market Share by Region (2019-2024)
Figure 30. North America Anti-TIGIT Antibody Sales and Growth Rate (2019-2024) & (K MT)
Figure 31. North America Anti-TIGIT Antibody Sales Market Share by Country in 2023
Figure 32. U.S. Anti-TIGIT Antibody Sales and Growth Rate (2019-2024) & (K MT)
Figure 33. Canada Anti-TIGIT Antibody Sales (K MT) and Growth Rate (2019-2024)
Figure 34. Mexico Anti-TIGIT Antibody Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Anti-TIGIT Antibody Sales and Growth Rate (2019-2024) & (K MT)
Figure 36. Europe Anti-TIGIT Antibody Sales Market Share by Country in 2023
Figure 37. Germany Anti-TIGIT Antibody Sales and Growth Rate (2019-2024) & (K MT)
Figure 38. France Anti-TIGIT Antibody Sales and Growth Rate (2019-2024) & (K MT)
Figure 39. U.K. Anti-TIGIT Antibody Sales and Growth Rate (2019-2024) & (K MT)
Figure 40. Italy Anti-TIGIT Antibody Sales and Growth Rate (2019-2024) & (K MT)
Figure 41. Russia Anti-TIGIT Antibody Sales and Growth Rate (2019-2024) & (K MT)
Figure 42. Asia Pacific Anti-TIGIT Antibody Sales and Growth Rate (K MT)
Figure 43. Asia Pacific Anti-TIGIT Antibody Sales Market Share by Region in 2023
Figure 44. China Anti-TIGIT Antibody Sales and Growth Rate (2019-2024) & (K MT)
Figure 45. Japan Anti-TIGIT Antibody Sales and Growth Rate (2019-2024) & (K MT)
Figure 46. South Korea Anti-TIGIT Antibody Sales and Growth Rate (2019-2024) & (K MT)
Figure 47. India Anti-TIGIT Antibody Sales and Growth Rate (2019-2024) & (K MT)
Figure 48. Southeast Asia Anti-TIGIT Antibody Sales and Growth Rate (2019-2024) & (K MT)
Figure 49. South America Anti-TIGIT Antibody Sales and Growth Rate (K MT)
Figure 50. South America Anti-TIGIT Antibody Sales Market Share by Country in 2023
Figure 51. Brazil Anti-TIGIT Antibody Sales and Growth Rate (2019-2024) & (K MT)
Figure 52. Argentina Anti-TIGIT Antibody Sales and Growth Rate (2019-2024) & (K MT)
Figure 53. Columbia Anti-TIGIT Antibody Sales and Growth Rate (2019-2024) & (K MT)
Figure 54. Middle East and Africa Anti-TIGIT Antibody Sales and Growth Rate (K MT)
Figure 55. Middle East and Africa Anti-TIGIT Antibody Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Anti-TIGIT Antibody Sales and Growth Rate (2019-2024) & (K MT)
Figure 57. UAE Anti-TIGIT Antibody Sales and Growth Rate (2019-2024) & (K MT)
Figure 58. Egypt Anti-TIGIT Antibody Sales and Growth Rate (2019-2024) & (K MT)
Figure 59. Nigeria Anti-TIGIT Antibody Sales and Growth Rate (2019-2024) & (K MT)
Figure 60. South Africa Anti-TIGIT Antibody Sales and Growth Rate (2019-2024) & (K MT)
Figure 61. Global Anti-TIGIT Antibody Production Market Share by Region (2019-2024)
Figure 62. North America Anti-TIGIT Antibody Production (K MT) Growth Rate (2019-2024)
Figure 63. Europe Anti-TIGIT Antibody Production (K MT) Growth Rate (2019-2024)
Figure 64. Japan Anti-TIGIT Antibody Production (K MT) Growth Rate (2019-2024)
Figure 65. China Anti-TIGIT Antibody Production (K MT) Growth Rate (2019-2024)
Figure 66. Global Anti-TIGIT Antibody Sales Forecast by Volume (2019-2032) & (K MT)
Figure 67. Global Anti-TIGIT Antibody Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global Anti-TIGIT Antibody Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global Anti-TIGIT Antibody Market Share Forecast by Type (2025-2032)
Figure 70. Global Anti-TIGIT Antibody Sales Forecast by Application (2025-2032)
Figure 71. Global Anti-TIGIT Antibody Market Share Forecast by Application (2025-2032)
Figure 1. Product Picture of Anti-TIGIT Antibody
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Anti-TIGIT Antibody Market Size (M USD), 2019-2032
Figure 5. Global Anti-TIGIT Antibody Market Size (M USD) (2019-2032)
Figure 6. Global Anti-TIGIT Antibody Sales (K MT) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Anti-TIGIT Antibody Market Size by Country (M USD)
Figure 11. Anti-TIGIT Antibody Sales Share by Manufacturers in 2023
Figure 12. Global Anti-TIGIT Antibody Revenue Share by Manufacturers in 2023
Figure 13. Anti-TIGIT Antibody Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Anti-TIGIT Antibody Average Price (USD/MT) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Anti-TIGIT Antibody Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Anti-TIGIT Antibody Market Share by Type
Figure 18. Sales Market Share of Anti-TIGIT Antibody by Type (2019-2024)
Figure 19. Sales Market Share of Anti-TIGIT Antibody by Type in 2023
Figure 20. Market Size Share of Anti-TIGIT Antibody by Type (2019-2024)
Figure 21. Market Size Market Share of Anti-TIGIT Antibody by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Anti-TIGIT Antibody Market Share by Application
Figure 24. Global Anti-TIGIT Antibody Sales Market Share by Application (2019-2024)
Figure 25. Global Anti-TIGIT Antibody Sales Market Share by Application in 2023
Figure 26. Global Anti-TIGIT Antibody Market Share by Application (2019-2024)
Figure 27. Global Anti-TIGIT Antibody Market Share by Application in 2023
Figure 28. Global Anti-TIGIT Antibody Sales Growth Rate by Application (2019-2024)
Figure 29. Global Anti-TIGIT Antibody Sales Market Share by Region (2019-2024)
Figure 30. North America Anti-TIGIT Antibody Sales and Growth Rate (2019-2024) & (K MT)
Figure 31. North America Anti-TIGIT Antibody Sales Market Share by Country in 2023
Figure 32. U.S. Anti-TIGIT Antibody Sales and Growth Rate (2019-2024) & (K MT)
Figure 33. Canada Anti-TIGIT Antibody Sales (K MT) and Growth Rate (2019-2024)
Figure 34. Mexico Anti-TIGIT Antibody Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Anti-TIGIT Antibody Sales and Growth Rate (2019-2024) & (K MT)
Figure 36. Europe Anti-TIGIT Antibody Sales Market Share by Country in 2023
Figure 37. Germany Anti-TIGIT Antibody Sales and Growth Rate (2019-2024) & (K MT)
Figure 38. France Anti-TIGIT Antibody Sales and Growth Rate (2019-2024) & (K MT)
Figure 39. U.K. Anti-TIGIT Antibody Sales and Growth Rate (2019-2024) & (K MT)
Figure 40. Italy Anti-TIGIT Antibody Sales and Growth Rate (2019-2024) & (K MT)
Figure 41. Russia Anti-TIGIT Antibody Sales and Growth Rate (2019-2024) & (K MT)
Figure 42. Asia Pacific Anti-TIGIT Antibody Sales and Growth Rate (K MT)
Figure 43. Asia Pacific Anti-TIGIT Antibody Sales Market Share by Region in 2023
Figure 44. China Anti-TIGIT Antibody Sales and Growth Rate (2019-2024) & (K MT)
Figure 45. Japan Anti-TIGIT Antibody Sales and Growth Rate (2019-2024) & (K MT)
Figure 46. South Korea Anti-TIGIT Antibody Sales and Growth Rate (2019-2024) & (K MT)
Figure 47. India Anti-TIGIT Antibody Sales and Growth Rate (2019-2024) & (K MT)
Figure 48. Southeast Asia Anti-TIGIT Antibody Sales and Growth Rate (2019-2024) & (K MT)
Figure 49. South America Anti-TIGIT Antibody Sales and Growth Rate (K MT)
Figure 50. South America Anti-TIGIT Antibody Sales Market Share by Country in 2023
Figure 51. Brazil Anti-TIGIT Antibody Sales and Growth Rate (2019-2024) & (K MT)
Figure 52. Argentina Anti-TIGIT Antibody Sales and Growth Rate (2019-2024) & (K MT)
Figure 53. Columbia Anti-TIGIT Antibody Sales and Growth Rate (2019-2024) & (K MT)
Figure 54. Middle East and Africa Anti-TIGIT Antibody Sales and Growth Rate (K MT)
Figure 55. Middle East and Africa Anti-TIGIT Antibody Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Anti-TIGIT Antibody Sales and Growth Rate (2019-2024) & (K MT)
Figure 57. UAE Anti-TIGIT Antibody Sales and Growth Rate (2019-2024) & (K MT)
Figure 58. Egypt Anti-TIGIT Antibody Sales and Growth Rate (2019-2024) & (K MT)
Figure 59. Nigeria Anti-TIGIT Antibody Sales and Growth Rate (2019-2024) & (K MT)
Figure 60. South Africa Anti-TIGIT Antibody Sales and Growth Rate (2019-2024) & (K MT)
Figure 61. Global Anti-TIGIT Antibody Production Market Share by Region (2019-2024)
Figure 62. North America Anti-TIGIT Antibody Production (K MT) Growth Rate (2019-2024)
Figure 63. Europe Anti-TIGIT Antibody Production (K MT) Growth Rate (2019-2024)
Figure 64. Japan Anti-TIGIT Antibody Production (K MT) Growth Rate (2019-2024)
Figure 65. China Anti-TIGIT Antibody Production (K MT) Growth Rate (2019-2024)
Figure 66. Global Anti-TIGIT Antibody Sales Forecast by Volume (2019-2032) & (K MT)
Figure 67. Global Anti-TIGIT Antibody Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global Anti-TIGIT Antibody Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global Anti-TIGIT Antibody Market Share Forecast by Type (2025-2032)
Figure 70. Global Anti-TIGIT Antibody Sales Forecast by Application (2025-2032)
Figure 71. Global Anti-TIGIT Antibody Market Share Forecast by Application (2025-2032)
